LSV Asset Management’s Corcept Therapeutics CORT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,163
| Closed | -$158K | – | 873 |
|
|
2022
Q3 | $158K | Sell |
6,163
-1,714
| -22% | -$43.9K | ﹤0.01% | 807 |
|
|
2022
Q2 | $187K | Sell |
7,877
-1,629
| -17% | -$38.7K | ﹤0.01% | 811 |
|
|
2022
Q1 | $214K | Sell |
9,506
-28,190
| -75% | -$635K | ﹤0.01% | 823 |
|
|
2021
Q4 | $746K | Sell |
37,696
-36,304
| -49% | -$718K | ﹤0.01% | 734 |
|
|
2021
Q3 | $1.46M | Sell |
74,000
-174,100
| -70% | -$3.43M | ﹤0.01% | 674 |
|
|
2021
Q2 | $5.46M | Sell |
248,100
-145,800
| -37% | -$3.21M | 0.01% | 549 |
|
|
2021
Q1 | $9.37M | Sell |
393,900
-326,500
| -45% | -$7.77M | 0.02% | 480 |
|
|
2020
Q4 | $18.8M | Sell |
720,400
-864,500
| -55% | -$22.6M | 0.03% | 376 |
|
|
2020
Q3 | $27.6M | Sell |
1,584,900
-55,181
| -3% | -$960K | 0.06% | 291 |
|
|
2020
Q2 | $27.6M | Sell |
1,640,081
-243,543
| -13% | -$4.1M | 0.06% | 302 |
|
|
2020
Q1 | $22.4M | Buy |
1,883,624
+165,200
| +10% | +$1.96M | 0.05% | 286 |
|
|
2019
Q4 | $20.8M | Buy |
1,718,424
+629,038
| +58% | +$7.61M | 0.03% | 375 |
|
|
2019
Q3 | $15.4M | Buy |
1,089,386
+534,286
| +96% | +$7.55M | 0.03% | 408 |
|
|
2019
Q2 | $6.19M | Buy |
555,100
+442,200
| +392% | +$4.93M | 0.01% | 531 |
|
|
2019
Q1 | $1.33M | Hold |
112,900
| – | – | ﹤0.01% | 727 |
|
|
2018
Q4 | $1.51M | Buy |
+112,900
| New | +$1.51M | ﹤0.01% | 729 |
|